A Leicester teen is “really well” after being the first to receive a pioneering blood cancer treatment. Alyssa Tapley was ...

CRISPR Therapeutics recently drew attention as updates highlighted progress in its gene-editing pipeline, including early-stage studies of CTX310, an in vivo therapy designed to lower LDL cholesterol ...

If you have been wondering whether CRISPR Therapeutics at around $57 a share is a bargain or a bubble, you are not alone. This stock sits at the crossroads of high science and high expectations. The ...

Seq, a CRISPR-based method that enriches ultra-rare tumor DNA in blood by removing background wild-type DNA before sequencing ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...

A Mount Sinai team showed that the same leukemia mutation behaves differently depending on when it arises during development.

Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...

AI-generated design images are reshaping home decor inspiration — sparking creativity, confusion and debate among ...

Patients who receive T-cell redirecting therapies are typically hospitalized for several days after treatment to watch for ...

Scientists have used a new type of gene therapy to cure leukaemia patients. The treatment, which uses edited immune cells ...

DNA can sustain serious injuries called double strand breaks, in which both strands of the helix snap. These breaks are among ...